PDA Conference: Baxter Cuts 483 Rate with Quality Matrix

Drug GMP Report
A A
Drug companies can move beyond simply satisfying FDA regulations by meticulously tracking quality elements, Baxter International quality expert Kevin Cloonan said Monday at the PDA/FDA Joint Regulatory Conference in Washington, D.C.

To View This Article:

Login

Subscribe To Drug GMP Report